Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1982 1
1985 2
1989 2
1992 3
1997 2
1999 1
2000 1
2002 1
2005 1
2009 1
2010 2
2011 1
2012 2
2013 3
2015 2
2016 3
2017 4
2018 5
2019 6
2020 2
2021 8
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Nutrition, osteoarthritis and cartilage metabolism.
Messina OD, Vidal Wilman M, Vidal Neira LF. Messina OD, et al. Aging Clin Exp Res. 2019 Jun;31(6):807-813. doi: 10.1007/s40520-019-01191-w. Epub 2019 Apr 13. Aging Clin Exp Res. 2019. PMID: 30982220 Review.
Refractory fibromyalgia.
Vidal LF, Messina O, Rodríguez T, Vidal M, Pineda C, Morales R, Collado A. Vidal LF, et al. Among authors: messina o. Clin Rheumatol. 2021 Sep;40(9):3853-3858. doi: 10.1007/s10067-021-05818-0. Epub 2021 Jun 24. Clin Rheumatol. 2021. PMID: 34169373 Review.
Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial.
Saag KG, Pannacciulli N, Geusens P, Adachi JD, Messina OD, Morales-Torres J, Emkey R, Butler PW, Yin X, Lems WF. Saag KG, et al. Among authors: messina od. Arthritis Rheumatol. 2019 Jul;71(7):1174-1184. doi: 10.1002/art.40874. Epub 2019 May 25. Arthritis Rheumatol. 2019. PMID: 30816640 Free PMC article. Clinical Trial.
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial.
Westhovens R, Rigby WFC, van der Heijde D, Ching DWT, Stohl W, Kay J, Chopra A, Bartok B, Matzkies F, Yin Z, Guo Y, Tasset C, Sundy JS, Jahreis A, Mozaffarian N, Messina OD, Landewé RB, Atsumi T, Burmester GR. Westhovens R, et al. Among authors: messina od. Ann Rheum Dis. 2021 Jun;80(6):727-738. doi: 10.1136/annrheumdis-2020-219213. Epub 2021 Jan 15. Ann Rheum Dis. 2021. PMID: 33452004 Free PMC article. Clinical Trial.
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study.
Saag KG, Wagman RB, Geusens P, Adachi JD, Messina OD, Emkey R, Chapurlat R, Wang A, Pannacciulli N, Lems WF. Saag KG, et al. Among authors: messina od. Lancet Diabetes Endocrinol. 2018 Jun;6(6):445-454. doi: 10.1016/S2213-8587(18)30075-5. Epub 2018 Apr 6. Lancet Diabetes Endocrinol. 2018. PMID: 29631782 Clinical Trial.
Management of glucocorticoid-induced osteoporosis.
Messina OD, Vidal LF, Wilman MV, Bultink IEM, Raterman HG, Lems W. Messina OD, et al. Aging Clin Exp Res. 2021 Apr;33(4):793-804. doi: 10.1007/s40520-021-01823-0. Epub 2021 Mar 22. Aging Clin Exp Res. 2021. PMID: 33751462 Review.
Osteoporosis: a clinical and pharmacological update.
Vidal M, Thibodaux RJ, Neira LFV, Messina OD. Vidal M, et al. Among authors: messina od. Clin Rheumatol. 2019 Feb;38(2):385-395. doi: 10.1007/s10067-018-4370-1. Epub 2018 Dec 12. Clin Rheumatol. 2019. PMID: 30542797 Review.
Correction to: Management of glucocorticoid-induced osteoporosis.
Messina OD, Vidal LF, Wilman MV, Bultink IEM, Raterman HG, Lems W. Messina OD, et al. Aging Clin Exp Res. 2021 Jul 23. doi: 10.1007/s40520-021-01937-5. Online ahead of print. Aging Clin Exp Res. 2021. PMID: 34297337 No abstract available.
Biologic therapies and bone loss in rheumatoid arthritis.
Zerbini CAF, Clark P, Mendez-Sanchez L, Pereira RMR, Messina OD, Uña CR, Adachi JD, Lems WF, Cooper C, Lane NE; IOF Chronic Inflammation and Bone Structure (CIBS) Working Group. Zerbini CAF, et al. Among authors: messina od. Osteoporos Int. 2017 Feb;28(2):429-446. doi: 10.1007/s00198-016-3769-2. Epub 2016 Oct 31. Osteoporos Int. 2017. PMID: 27796445 Review.
50 results